Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR
暂无分享,去创建一个
Ruben Abagyan | Richard H. Griffey | Anton V. Filikov | Thomas L. James | Venkatraman Mohan | Timothy A. Vickers | P. Dan Cook | R. Abagyan | R. Griffey | V. Mohan | T. James | T. Vickers | P. D. Cook | A. Filikov
[1] D. Richman,et al. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. , 1991, Science.
[2] M Sumner-Smith,et al. Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure , 1992, Journal of virology.
[3] D A Agard,et al. Computational method for the design of enzymes with altered substrate specificity. , 1991, Journal of molecular biology.
[4] B. Sullenger,et al. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation , 1991, Journal of virology.
[5] K. P. Murphy,et al. Structural energetics of peptide recognition: Angiotensin II/antibody binding , 1993, Proteins.
[6] B. Peterlin,et al. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators , 1992, Journal of virology.
[7] Ruben Abagyan,et al. Efficient parallelization of the energy, surface, and derivative calculations for internal coordinate mechanics , 1994, J. Comput. Chem..
[8] Pieter F. W. Stouten,et al. A molecular mechanics/grid method for evaluation of ligand–receptor interactions , 1995, J. Comput. Chem..
[9] Hans-Joachim Böhm,et al. Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs , 1998, J. Comput. Aided Mol. Des..
[10] Randy J. Read,et al. A multiple‐start Monte Carlo docking method , 1992 .
[11] Kevin P. Clark,et al. Flexible ligand docking without parameter adjustment across four ligand–receptor complexes , 1995, J. Comput. Chem..
[12] M. Mizutani,et al. Rational automatic search method for stable docking models of protein and ligand. , 1994, Journal of molecular biology.
[13] J. Karn,et al. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. , 1995, Journal of molecular biology.
[14] Y Wang,et al. RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities. , 1996, Biochemistry.
[15] I D Kuntz,et al. Structure-based discovery of ligands targeted to the RNA double helix. , 1997, Biochemistry.
[16] D K Gehlhaar,et al. De novo design of enzyme inhibitors by Monte Carlo ligand generation. , 1995, Journal of medicinal chemistry.
[17] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[18] D M Crothers,et al. Fragments of the HIV-1 Tat protein specifically bind TAR RNA. , 1990, Science.
[19] Thomas Lengauer,et al. A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.
[20] M J Sternberg,et al. Empirical scale of side-chain conformational entropy in protein folding. , 1993, Journal of molecular biology.
[21] M C Hsu,et al. The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter , 1995, Journal of virology.
[22] J T Finch,et al. RNA binding by the tat and rev proteins of HIV-1. , 1991, Biochimie.
[23] F. Young. Biochemistry , 1955, The Indian Medical Gazette.
[24] J. Puglisi,et al. Conformation of the TAR RNA-arginine complex by NMR spectroscopy. , 1992, Science.
[25] T R Bailey,et al. Keto/enol epoxy steroids: a new structural class of HIV-1 Tat inhibitors. , 1993, Journal of medicinal chemistry.
[26] S Vajda,et al. Effect of conformational flexibility and solvation on receptor-ligand binding free energies. , 1994, Biochemistry.
[27] P. Sharp,et al. HIV‐1 Tat protein promotes formation of more‐processive elongation complexes. , 1991, The EMBO journal.
[28] P. Weiner,et al. Computer Simulation of Biomolecular Systems , 1997 .
[29] Anton V. Filikov,et al. Structure-based design of ligands for protein basic domains: Application to the HIV-1 Tat protein , 1998, J. Comput. Aided Mol. Des..
[30] T. James,et al. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA. , 1996, Journal of biomolecular structure & dynamics.
[31] A Caflisch,et al. Monte carlo minimization with thermalization for global optimization of polypeptide conformations in cartesian coordinate space , 1992, Proteins.
[32] J. Vos,et al. Dating Hominid Sites in Indonesia , 1994 .
[33] B Tidor,et al. Arginine-mediated RNA recognition: the arginine fork , 1991, Science.
[34] I. Kuntz,et al. Automated docking with grid‐based energy evaluation , 1992 .
[35] P. Luciw,et al. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product , 1987, Nature.
[36] Wilfred F. van Gunsteren,et al. Computer Simulation of Biomolecular Systems: Theoretical and Experimental Applications , 1989 .
[37] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[38] H J Berendsen,et al. Molecular dynamics simulation of the docking of substrates to proteins , 1994, Proteins.
[39] D. Patel,et al. Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex. , 1997, Chemistry & biology.
[40] J. Karn,et al. Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. , 1996, Nucleic acids research.
[41] J. Puglisi,et al. Solution Structure of a Bovine Immunodeficiency Virus Tat-TAR Peptide-RNA Complex , 1995, Science.
[42] P Argos,et al. Optimal protocol and trajectory visualization for conformational searches of peptides and proteins. , 1992, Journal of molecular biology.
[43] R. Bruccoleri,et al. On the attribution of binding energy in antigen-antibody complexes McPC 603, D1.3, and HyHEL-5. , 1989, Biochemistry.
[44] D F Hoth,et al. Present status and future prospects for HIV therapies. , 1993, Science.
[45] D. Patel,et al. Molecular recognition in the FMN-RNA aptamer complex. , 1996, Journal of molecular biology.
[46] Johan Desmet,et al. The dead-end elimination theorem and its use in protein side-chain positioning , 1992, Nature.
[47] D. Ecker,et al. Pseudo--half-knot formation with RNA. , 1992, Science.
[48] E Westhof,et al. Structural Basis of Ligand Discrimination by Two Related RNA Aptamers Resolved by NMR Spectroscopy , 1996, Science.
[49] H. Scheraga,et al. Energy parameters in polypeptides. VII. Geometric parameters, partial atomic charges, nonbonded interactions, hydrogen bond interactions, and intrinsic torsional potentials for the naturally occurring amino acids , 1975 .
[50] I. Kuntz,et al. Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. , 1988, Journal of medicinal chemistry.
[51] J. Scott Dixon,et al. Flexible ligand docking using a genetic algorithm , 1995, J. Comput. Aided Mol. Des..
[52] I. Kuntz,et al. Conformational analysis of flexible ligands in macromolecular receptor sites , 1992 .
[53] M. Malim,et al. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein , 1989, Journal of virology.